| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |